The sale is part of a pre-arranged 10b5-1 plan adopted in July 2026, reducing the signal value. However, the cumulative insider selling volume ($11.9M in 30 days) is notable for a $2.6B market cap company. Monitor for any change in the pace of insider sales or unexpected departures.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 11 $36.50entry
- T+1 · 5d ago +0.22%α +0.57% · $36.58
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Peter Anevski, a director and officer of Progyny, filed a Form 144 notice of intent to sell 50,139 shares of common stock valued at approximately $1.8 million. The filing also discloses recent sales by Anevski and a related trust totaling over $6.1 million in the prior week, all executed under Rule 10b5-1 trading plans.
Key Facts
- Peter Anevski (Director and Officer) filed Form 144 to sell 50,139 shares of common stock.
- The proposed sale has an approximate market value of $1,802,497.05 based on the filing date.
- The filing also reports recent 10b5-1 plan sales by Anevski and a related trust on 11/09/2026 totaling $5,762,841.21 and on 11/05/2026 totaling $419,412.68.
- The shares to be sold were acquired upon vesting of restricted stock units, performance stock units, and employee stock purchase plan from 1/1/2022 through 3/3/2026.
- The filing indicates a 10b5-1 trading plan was adopted on 07/02/2026.
- Total insider sales in the 30 days before the snapshot were $11.9M, consistent with this pattern.
Financial Impact
Proposed sale of 50,139 shares valued at ~$1.8M, representing about 0.07% of market cap. Recent total sales by this insider and trust exceed $6.1M.
Risk Factors
- Insider selling may be perceived as lack of confidence, though 10b5-1 plans mitigate this.
- Continued large-scale insider sales could pressure the stock if not offset by institutional buying.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010961 |
| Document: 0001950047-26-010961-index.html | 0001950047-26-010961 |
| Document: 0001950047-26-010961.txt | 0001950047-26-010961 |
Track record
26 reports on PGNY
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Viewing Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers